Primary study · included by 1 review

Surgery combined with postoperative 125 I seed brachytherapy for the treatment of mucoepidermoid carcinoma of the parotid gland in pediatric patients.

Mao M, 2017 · Mao Ming-Hui, Zheng Lei, Wang Xi-Ming, et al. · Pediatric blood & cancer · 2017

Included by

Prognostic Factors and Survival Outcomes in Parotid Gland Mucoepidermoid Carcinoma: A Systematic Review with Meta-Analysis and Workflow Proposal.

Non-Cochrane · prognostic · 2026 · cited as Mao 2017 · Reference 17; Figures 2 to 4

Outcome this study informs	Pooled effect	Evidence	Certainty
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.8 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.9 [0.8, 0.9]	10 studies · 2341 participants	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.8 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.8 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.9 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.8 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.8 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.8 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.9 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.9 [0.8, 0.9]	9 studies	GRADE not reported
5-year overall survival Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 5 years	Proportion 0.8 [0.8, 0.9]	9 studies	GRADE not reported

1 including review in total.